Patterns of survival in patients with Hodgkin's disease: long follow up in a single centre.
暂无分享,去创建一个
A G Stansfeld | A. Oza | A. Jones | W. Gregory | A. Stansfeld | T. Ganesan | W Gregory | T S Ganesan | J. Amess | A M Oza | M Leahy | J Lim | L Dadiotis | V Barbounis | A E Jones | J Amess | V. Barbounis | J. Lim | M. Leahy | L. Dadiotis
[1] A. Stansfeld,et al. Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy. , 1980, Clinical oncology.
[2] B. Hillner,et al. The optimal timing of autologous bone marrow transplantation in Hodgkin's disease patients after a chemotherapy relapse. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] D. Bergsagel. Salvage treatment for Hodgkin's disease in relapse. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] M Tubiana,et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] J. Connors,et al. MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] A. Santoro,et al. Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience. , 1991, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] E. Jaffe,et al. Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] J. Vardiman,et al. Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations. , 1977, Blood.
[9] T. Lister,et al. The treatment of stage IIIA Hodgkin's disease. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] P. Mazza,et al. High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] A. Oza,et al. Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years. , 1992, British Journal of Cancer.
[12] R. Fisher,et al. Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. , 1979, Annals of internal medicine.
[13] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[14] S. Rosenberg,et al. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy , 1978, Cancer.
[15] S. Piantadosi,et al. High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] T. Lister,et al. Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres. , 1988, British Journal of Cancer.
[17] M Tubiana,et al. Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.
[18] A. Santoro,et al. Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease. , 1982, Annals of internal medicine.
[19] J. Armitage,et al. Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] D. Cox. Regression Models and Life-Tables , 1972 .
[21] J. Connors,et al. Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988. , 1991, Blood.
[22] A. Varghese,et al. Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] T. Miller,et al. Radiation therapy salvage of Hodgkin's disease following chemotherapy failure. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] F. Cabanillas,et al. Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.